Senores Pharma: Authorizes KMPs for Disclosure Post CS Resignation

Senores Pharmaceuticals Limited has updated its disclosure authorization following the resignation of its Company Secretary and Compliance Officer, Mr. Vinay Kumar Mishra, effective June 10, 2026. The company has authorized its Managing Director, Mr. Swapnil Jatinbhai Shah, and Whole Time Director & CFO, Mr. Deval Rajnikant Shah, to determine the materiality of events and make disclosures to the stock exchanges as per SEBI (LODR) Regulations, 2015. This update follows their earlier intimation on May 14, 2026, regarding Mr. Mishra's resignation.